Genentech

Genentech, Inc. is a leading American biotechnology company based in South San Francisco, California. Founded in 1976, it is recognized as the world's first biotechnology company and has played a significant role in pioneering recombinant DNA technology. As a member of the Roche Group since 2009, Genentech focuses on discovering, developing, manufacturing, and commercializing medicines for serious and life-threatening diseases. The company has made numerous groundbreaking contributions to medicine, including the development of the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Its product portfolio features important treatments such as human insulin, human growth hormone, and Lucentis for eye diseases. Genentech emphasizes innovation and collaboration, partnering with academic institutions and industry leaders to advance biotechnology and address unmet medical needs. With a strong commitment to research and development, Genentech continues to expand its pipeline of potential blockbuster drugs.